HomeCompareALNA vs JEPQ

ALNA vs JEPQ: Dividend Comparison 2026

ALNA yields 2666.67% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ALNA wins by $148430280508.28M in total portfolio value
10 years
ALNA
ALNA
● Live price
2666.67%
Share price
$0.08
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$148430280508.33M
Annual income
$138,233,078,461,413,420.00
Full ALNA calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — ALNA vs JEPQ

📍 ALNA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodALNAJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ALNA + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ALNA pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ALNA
Annual income on $10K today (after 15% tax)
$226,666.67/yr
After 10yr DRIP, annual income (after tax)
$117,498,116,692,201,400.00/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, ALNA beats the other by $117,498,116,692,199,580.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ALNA + JEPQ for your $10,000?

ALNA: 50%JEPQ: 50%
100% JEPQ50/50100% ALNA
Portfolio after 10yr
$74215140254.19M
Annual income
$69,116,539,230,707,790.00/yr
Blended yield
93.13%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ALNA right now

ALNA
Analyst Ratings
1
Buy
Consensus: Buy
JEPQ
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ALNA buys
0
JEPQ buys
0
No recent congressional trades found for ALNA or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricALNAJEPQ
Forward yield2666.67%11.10%
Annual dividend / share$2.00$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$148430280508.33M$44.8K
Annual income after 10y$138,233,078,461,413,420.00$2,152.59
Total dividends collected$147720561198.01M$16.3K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: ALNA vs JEPQ ($10,000, DRIP)

YearALNA PortfolioALNA Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$277,367$266,666.67$11,930$1,110.39+$265.4KALNA
2$7,209,347$6,912,564.90$14,133$1,224.34+$7.20MALNA
3$175,631,950$167,917,948.81$16,632$1,340.46+$175.62MALNA
4$4,011,072,538$3,823,146,351.60$19,454$1,457.97+$4011.05MALNA
5$85,892,595,210$81,600,747,594.12$22,626$1,576.08+$85892.57MALNA
6$1,724,977,965,006$1,633,072,888,131.25$26,175$1,694.09+$1724977.94MALNA
7$32,497,077,175,537$30,651,350,752,980.08$30,133$1,811.32+$32497077.15MALNA
8$574,439,777,193,002$539,667,904,615,177.50$34,531$1,927.17+$574439777.16MALNA
9$9,530,095,370,946,888$8,915,444,809,350,376.00$39,403$2,041.08+$9530095370.91MALNA
10$148,430,280,508,326,560$138,233,078,461,413,420.00$44,787$2,152.59+$148430280508.28MALNA

ALNA vs JEPQ: Complete Analysis 2026

ALNAStock

Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts.

Full ALNA Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this ALNA vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ALNA vs SCHDALNA vs JEPIALNA vs OALNA vs KOALNA vs MAINALNA vs XYLDALNA vs QYLDALNA vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.